Manufacturing plasma-derived medicinal products
In the highly specialised field of plasma-derived medicinal products, LFB draws on its pharmaceutical and industrial expertise and know-how to develop its work in technology transfer.
Major collaboration in Brazil
Since 2007 the first technology transfer has been undertaken with the Brazilian State-owned company HEMOBRAS. For this, a plasma fractionation facility is being constructed in northern Brazil. This plant will allow essential medicinal products to be manufactured in Brazil, from plasma collected within the country.